Pre-treatment with irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation

Left atrial (LA) stunning, the transient impairment of LA function, is responsible for an increased thrombo-embolic risk after cardioversion of atrial fibrillation (AF). Angiotensin receptor blockers (ARBs) attenuate atrial remodelling in AF and could theoretically influence LA stunning. We studied...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal 2006-09, Vol.27 (17), p.2062-2068
Hauptverfasser:	GOETTE, Andreas, SCHOTTEN, Ulrich, KREMASTINOS, Dimitrios Th, COKKINOS, Dennis V, DAGRES, Nikolaos, KARATASAKIS, George, PANOU, Fotios, ATHANASSOPOULOS, Georgios, MAOUNIS, Themistoclis, TSOUGOS, Elias, KOUREA, Kallirrhoe, MALAKOS, Ioannis
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Angiotensin II Type 1 Receptor Blockers - therapeutic use Atrial Fibrillation - physiopathology Atrial Fibrillation - therapy Atrial Function, Left - physiology Biological and medical sciences Biphenyl Compounds - therapeutic use Cardiac dysrhythmias Cardiology. Vascular system Case-Control Studies Echocardiography Electric Countershock Female Heart Humans Male Medical sciences Middle Aged Prospective Studies Tetrazoles - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!